(Q43819085)

27 November 2017

The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study (English)

1 reference

27 November 2017

0 references

4

Olsen J

1 reference

27 November 2017

1

Czeizel AE

1 reference

27 November 2017

Rockenbauer M

2

1 reference

PubMed ID

11738517

27 November 2017

Sørensen HT

series ordinal

3

1 reference

27 November 2017

1 November 2001

1 reference

27 November 2017

Reproductive Toxicology

1 reference

27 November 2017

15

1 reference

27 November 2017

637-646

1 reference

27 November 2017

6

1 reference

Drugs and folate metabolism

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Trimethoprim-Sulfonamide Combination Administered Orally and Intravaginally in the First Trimester of Pregnancy: Its Absorption into Serum and Transfer to Amniotic Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

First 25 years of the Hungarian congenital abnormality registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

The role of pharmacoepidemiology in pharmacovigilance: rational drug use in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 10. A new approach to germinal mutation surveillance: pair-wise evaluation of component elements in unidentified multiple congenital abn

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Drug use during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Co-trimoxazole in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Holoprosencephaly and maternal low‐calorie weight‐reducing diet

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Niikawa-Kuroki syndrome: a new malformation syndrome of postnatal dwarfism, mental retardation, unusual face, and protruding ears.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Folic acid antagonists during pregnancy and the risk of birth defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Double-blind Trial to Compare Ampicillin, Cephalexin, Co-trimoxazole, and Trimethoprim in Treatment of Urinary Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Trimethoprim-Sulfamethoxazole in the Treatment of Bacteriuria in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Single-dose antibacterial treatment for bacteriuria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

A case-control analysis of the teratogenic effects of co-trimoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Congenital cardiovascular anomalies induced by pteroylglutamic acid deficiency during gestation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

ABNORMALITIES OF PULMONARY AND OTHER VESSELS IN RAT FETUSES FROM MATERNAL PTEROYLGLUTAMIC ACID DEFICIENCY

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Abnormalities of the urinary system of rat embryos resulting from maternal pteroylglutamic acid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Multiple congenital abnormalities resulting from transitory deficiency of pteroylglutamic acid during gestation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Congenital anomalies due to attempted abortion with 4-aminopteroglutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Trimethoprim and fasting plasma homocysteine.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Prevention of congenital abnormalities by periconceptional multivitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Multivitamin Supplementation and Risk of Brith Defects

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Dose-dependent effect of folic acid on the prevention of orofacial clefts

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

Population-based case control study of folic acid supplementation during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2801%2900178-2

7 January 2021

10.1016/S0890-6238(01)00178-2

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11738517